Nencki Institute PAS has entered a research collaboration with Thereson, a company focusing on therapeutic magnetic resonance.

Laboratory of Mitochondrial Biology and Metabolism, led by professor Mariusz Więckowski, will support the company in the effort to expand the spectrum of applications of TMR® Therapeutic Magnetic Resonance, beyond wound care management.

Thereson is an Italian, medical device company, dedicated to the treatment of Vascular pathologies, related to Microcirculation, Orthopedic and Degenerative diseases. Their first medical device DIAPASON®, utilising TMR® Therapeutic Magnetic Resonance in wound care management, was launched to the market in 2017. The company is dedicated to clinical and scientific research and aims to demonstrate the effectiveness of the treatment through rigorously gathered experimental data.